Table 1 Patient characteristics
From: High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients
Variables | Total number (%) |
|---|---|
Gender | |
 Male | 100 (72.5) |
 Female | 38 (27.5) |
Age, years [median (IQR)] | 60 (53–69) |
Site | |
 Low | 43 (31.2) |
 Middle | 75 (54.3) |
 High | 20 (14.5) |
Tumor size | |
  > 5 cm | 63 (45.7) |
  ≤ 5 cm | 75 (54.3) |
cTNM | |
 II | 31 (22.5) |
 III | 107 (77.5) |
ypTNM | |
 0-I | 74 (53.6) |
 II-III | 64 (46.4) |
Histopathology | |
 Well differentiation | 6 (4.7) |
 Moderate differentiation | 109 (84.5) |
 Poor differentiation | 14 (10.9) |
LVI | |
 Positive | 8 (5.8) |
 Negative | 130 (94.2) |
PNI | |
 Positve | 17 (12.3) |
 Negative | 121 (87.7) |
Tumor deposits | |
 Positive | 20 (14.5) |
 Negative | 118 (85.5) |
TRG | |
 0–1 | 80 (58.0) |
 2–3 | 58 (42.0) |
LNH [median (IQR)] | 8.8 (5.0–12.0) |
CEA [median (IQR)] | 3.5 (1.8–4.1) |
FARI% [median (IQR)] | 7.7 (6.5–8.7) |
PNI [median (IQR)] | 45.9 (43.2–48.5) |
CFP | |
 Low | 95 (68.8) |
 High | 43 (31.2) |